| Members |
targetComponentId |
| Levofloxacin 5mg/mL infusion solution 100mL vial |
Levofloxacin 5 mg/mL solution for injection |
| Levofloxacin 5mg/ml ophthalmic solution |
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
| Levoleucovorin calcium 50mg powder for injection solution vial |
Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial |
| Levomethadyl acetate hydrochloride 10mg/mL oral solution |
Levomethadyl 10 mg/mL oral solution |
| Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system |
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
| Levonorgestrel 52mg intrauterine system |
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) |
| Levothyroxine sodium 0.05mg tablet |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
| Levothyroxine sodium 0.075mg tablet |
Levothyroxine sodium anhydrous 75 microgram oral tablet |
| Levothyroxine sodium 0.1mg tablet |
Levothyroxine sodium anhydrous 100 microgram oral tablet |
| Levothyroxine sodium 200mg tablet |
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) |
| Levothyroxine sodium o.05mg |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
| Leydig cell neoplasm of testis |
Leydig cell tumor of testis of uncertain behavior |
| Leydig cell tumor, no International Classification of Diseases for Oncology subtype |
Leydig cell tumor of uncertain behavior (morphologic abnormality) |
| Librarian/info.officer NOS |
Librarian/information officer |
| Librarian/information officer NOS (occupation) |
Librarian/information officer |
| Lichen NOS |
Lichen (disorder) |
| Lichen NOS |
Lichen (disorder) |
| Lichen sclerosus et atrophicus |
Lichen sclerosus |
| Lichen sclerosus et atrophicus of the vulva |
Lichen sclerosus of vulva (disorder) |
| Lichen sclerosus et atrophicus, bullous type |
Lichen sclerosus bullous type (disorder) |
| Liddle's syndrome |
Pseudoprimary hyperaldosteronism (disorder) |
| Lidocaine 1%/epinephrine (1:200000) injection solution 20mL vial |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| Lidocaine 1.5% injection solution vial |
Lidocaine only product in parenteral dose form |
| Lidocaine 2%/epinephrine (1:200000) injection solution 20mL vial |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine 2.5% topical ointment |
Lidocaine hydrochloride 25 mg/g cutaneous ointment |
| Lidocaine 2.5%/prilocaine 2.5% periodontal gel |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
| Lidocaine hydrochloride 0.1%/glucose 5% infusion solution bag |
Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 0.2%/glucose 5% infusion solution bag |
Lidocaine hydrochloride 2 mg/mL solution for injection |
| Lidocaine hydrochloride 0.4%/glucose 5% infusion solution bag |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 0.5% injection solution ampule |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 0.5% injection solution vial |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 0.6%/glucose 5% infusion solution bag |
Product containing precisely lidocaine hydrochloride 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 1% conventional release solution for injection ampule |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 1% injection |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 1% injection solution ampule |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 1% injection solution sterile ampule |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 1% injection solution vial |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 1%/epinephrine 1:100,000 injection solution vial |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
| Lidocaine hydrochloride 1%/epinephrine 1:200,000 injection solution vial |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| Lidocaine hydrochloride 1.5% injection solution ampule |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 1.5%/epinephrine 1:200,000 injection solution vial |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| Lidocaine hydrochloride 10%/epinephrine 0.1% topical iontophoretic patch |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
| Lidocaine hydrochloride 2% injection |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 2% injection solution 5 mL ampule |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 2% injection solution ampule |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 2% injection solution vial |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 2%/epinephrine 1:100,000 injection solution vial |
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 2%/epinephrine 1:200,000 injection solution vial |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| Lidocaine hydrochloride 2%/epinephrine 1:500,000 injection solution vial |
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride 4% injection solution ampule |
Lidocaine hydrochloride 40 mg/mL solution for injection |
| Lidocaine hydrochloride 5% injection solution |
Lidocaine only product in parenteral dose form |
| Lidocaine hydrochloride 5%/glucose 7.5% injection solution vial |
Lidocaine hydrochloride 50 mg/mL solution for injection |
| Lidocaine hydrochloride+epinephrine 0.5%/1:200,000 injection |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride+epinephrine 1%/1:100,000 injection |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
| Lidocaine hydrochloride+epinephrine 2%/1:80,000 cartridge |
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Lidocaine hydrochloride+epinephrine 4% conventional release nasal drops |
Adrenaline and lidocaine only product |
| Lidocaine hydrochloride+epinephrine 4% preservative free nasal drops |
Adrenaline and lidocaine only product |
| Lidocaine hydrochloride+fluorescein sodium 4%/0.25% conventional release eye drops |
Fluorescein stain and lidocaine only product |
| Lidocaine hydrochloride+fluorescein sodium 4%/0.25% single-use eye drops |
Fluorescein stain and lidocaine only product |
| Liepmann's apraxia |
Transcortical apraxia |
| Life assurance examination NOS |
Life assurance - examination |
| Life assurance examination NOS |
Life assurance - examination |
| Life assurance preliminary report NOS |
Life assurance report status |
| Life assurance preliminary report NOS |
Life assurance - preliminary report |
| Life circumstance problem |
Social and personal history finding |
| Life crisis NOS |
Life crisis |
| Life crisis NOS, life event |
Life crisis |
| Lifelong psychologic disorder |
Chronic mental disorder |
| Ligation of fallopian tube with crushing |
Ligation and crushing of bilateral fallopian tubes (procedure) |
| Ligation of organ NOC |
Ligation |
| Light laborer NOS |
Laborer |
| Light labourer NOS |
Laborer |
| Lignocaine 5% / Hydrocortisone acetate 0.275% ointment |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
| Lignocaine hydrochloride 1% injection(plastic amp) |
Lidocaine only product in parenteral dose form |
| Lignocaine hydrochloride+adrenaline 2%/1:200000 sterile wrapped injection |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| Lignocaine hydrochloride+glucose 5%/7.5% injection |
Lidocaine hydrochloride 50 mg/mL solution for injection |
| Lincomycin 300mg/mL injection |
Lincomycin only product in parenteral dose form |
| Lincomycin and derivatives allergy |
Allergy to drug |
| Lincomycin hydrochloride 300mg/mL injection solution ampule |
Lincomycin only product in parenteral dose form |
| Linezolid 100mg/5mL granules for oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Linezolid 100mg/5mL granules for oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Linezolid 100mg/5mL suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Linezolid 2mg/mL infusion solution 300mL bag |
Product containing precisely linezolid 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Liothyronine sodium preparation |
Product containing liothyronine (medicinal product) |
| Lip and oral cavity TNM finding |
American Joint Committee on Cancer allowable value |
| Lip flap |
Flap (substance) |
| Lip soft tissue X-ray |
Plain X-ray of lip (procedure) |
| Lipoma of spinal column |
Lipoma of spinal cord |
| Lipoprotein electroph. NOS |
Lipoprotein electrophoresis |
| Lipoprotein electroph. NOS |
Lipoprotein electrophoresis |
| Liposarcoma, no International Classification of Diseases for Oncology subtype |
Liposarcoma |
| Liposomal daunorubicin 2mg/mL injection emulsion |
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) |
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 10mL vial |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Liposuction of subcutaneous tissue NEC |
Liposuction of subcutaneous tissue |
| Liquid paraffin [eye] |
Product containing mineral oil (medicinal product) |
| Liquid paraffin [laxative] |
Product containing mineral oil (medicinal product) |
| Liraglutide 6mg/mL injection solution |
Product containing only liraglutide (medicinal product) |
| Lisinopril allergy |
Non-allergic hypersensitivity to lisinopril |
| Listed for hosp admission NOS |
Listed for admission to hospital |
| Listed for hosp admission NOS |
Listed for admission to hospital |
FHIR